CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

A new study reveals that modifying the CUL5 gene enhances CAR-T cell therapy for leukemia and lymphoma. This improves cell ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in ...

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But using microscopy to do this at scale can be challenging, particularly when ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

This platform allows for highly precise detection of disease-specific cell-free DNA (cfDNA), making it ideal for early disease diagnosis and public screening. The CRISPR-TB Blood test is suitable ...

We also plan to expand our custom oligo offerings to support gene assembly, antibody screening, and CRISPR HDR donor workflows.” Bill Efcavitch, Co-Founder of Molecular Assemblies, said, “We are ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...